Isaac Kinde is the founder of Thrive Earlier Detection. Thrive Earlier Detection has raised $367M in total funding. Latest round: Series B.
Isaac Kinde is a co-founder and head of research and innovation at Thrive Earlier Detection, a biotech startup that commercialized the CancerSEEK liquid biopsy test for early cancer detection. He helped invent the CancerSEEK technology at Johns Hopkins University. Thrive was acquired by Exact Sciences in 2020 for $2.15 billion.
Full founder directory · Investor directory · Company funding database · Fundraising library